Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement

Stopped early · Not applicable

Conditions studied: Osteoarthritis, Hip, Traumatic Arthritis of Hip

In brief

The purpose of this study is to document the clinical outcomes of several devices used in total hip replacement, including the Answer® hip stem, the Ranawat/Burnstein® acetabular shell, and Simplex® or Palacos® bone cement.

Key facts

Study ID

NCT00588861

Run by

Biomet Orthopedics, LLC

People needed

400

Starts

2002-09-01

Expected to finish

2010-05-01

Last updated by the study team

2017-01-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis
• Rheumatoid arthritis
• Correction of functional deformity
• Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable using other techniques

You may not qualify if…

• Infection, sepsis, and osteomyelitis

Where it is running

• Biomet Orthopedics, LLC — Warsaw, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.